Geron Corporation
GERNGeron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
7wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Imetelstat
Myelofibrosis
Imetelstat sodium
Locally Recurrent or Metastatic Breast Cancer
Imetelstat 4.7 mg/kg
Myelofibrosis
Imetelstat (7.5 mg/kg)
Multiple Myeloma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Imetelstat | Phase 3 | Myelofibrosis | - | - |
Imetelstat sodium | Phase 3 | Locally Recurrent or Metastatic Breast Cancer | - | - |
Imetelstat 4.7 mg/kg | Phase 2 | Myelofibrosis | - | - |
Imetelstat (7.5 mg/kg) | Phase 2 | Multiple Myeloma | - | - |
Myelofibrosis
2 drugs in this indication
Multiple Myeloma
1 drug in this indication
Locally Recurrent or Metastatic Breast Cancer
1 drug in this indication
Non-small Cell Lung Cancer
1 drug in this indication
Myelodysplastic Syndromes
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)